Edit
TRICIDA
http://www.tricida.com/?portfolioCats=34,23,29,35,22,24,30,25,28,31#new_tabLast activity: 24.01.2023
Tricida, Inc., is a privately-held, clinical stage, biopharmaceutical company focused on the discovery and development of non-absorbed therapies. Tricida’s lead investigational drug candidate, TRC101, represents a first-in-class approach to the treatment of metabolic acidosis, a common complication of chronic kidney disease (CKD) that can result in increased mortality, accelerated progression of kidney disease, progressive muscle breakdown and exacerbation of bone disease.
Location: United States, California, South San Francisco
Employees: 51-200
Total raised: $484.5M
Founded date: 2013
Investors 5
| Date | Name | Website |
| - | Avoro Capi... | avorocapit... |
| - | Hercules C... | htgc.com |
| - | OrbiMed | orbimed.co... |
| - | Vivo Capit... | vivocapita... |
| - | Longitude ... | longitudec... |
Funding Rounds 6
| Date | Series | Amount | Investors |
| 15.11.2021 | - | $42M | - |
| 28.03.2019 | - | $200M | Hercules C... |
| 05.03.2018 | - | $100M | - |
| 08.11.2017 | Series D | $57.5M | - |
| 27.07.2016 | Series C | $55M | Longitude ... |
| 04.03.2015 | Series B | $30M | - |
Mentions in press and media 26
| Date | Title | Description | Source |
| 24.01.2023 | The rise of venture debt: When biotechs should—and shouldn't... | Biotechs are operating on razor-thin margins, struggling in a market that just two years ago was flu... | fiercebiot... |
| 03.03.2022 | Russia's war in Ukraine is now delaying data readouts,... | A small cap biotech reported Wednesday that the Russian invasion of Ukraine will delay the in... | endpts.com... |
| 16.11.2021 | Tricida : Raises $42 Million in Registered Direct Equity Fin... | Tricida Raises $42 Million in Registered Direct Equity Financing SOUTH SAN FRANCISCO, Calif., Novem... | marketscre... |
| 15.11.2021 | Tricida Raises $42 Million in Registered Direct Equity Finan... | - | orbimed.co... |
| 15.11.2021 | Tricida Raises $42 Million in Registered Direct Equity Finan... | SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharm... | marketscre... |
| 15.11.2021 | Tricida Raises $42 Million in Registered Direct Equity Finan... | SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharm... | globenewsw... |
| 09.11.2021 | Tricida Announces Third Quarter 2021 Financial Results | SOUTH SAN FRANCISCO, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharm... | marketscre... |
| 15.09.2021 | Tricida : Investor Presentation, September 2021 | Slowing the Progression of Chronic Kidney Disease Tricida Investor Presentation September 2021 For... | marketscre... |
| 09.12.2020 | Tricida : End-of-Year Business Update Presentation | Treating Metabolic Acidosis and Slowing the Progression of Chronic Kidney Disease Investor Presen... | marketscre... |
| 09.12.2020 | TRICIDA, INC. Tricida : End-of-Year Business Update Present... | Treating Metabolic Acidosis and Slowing the Progression of Chronic Kidney Disease Investor Presen... | marketscre... |
Show more